Evidence map›Paper›PMID 42588060›Full record

Trial reportNutrients2026

2'-Fucosyllactose Effects on Preterm Growth, Tolerance, and Neurobehavior: A Double-Blind, Randomized, Placebo-Controlled Pilot.

Ethan A Mezoff, Qing Duan, Nicholas J Ollberding, Elizabeth J Reverri, Rachael H Buck, Bridget Barrett-Reis, Kimberly Yolton, Ardythe L Morrow

Abstract readRandomized Controlled TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ethan A MezoffDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH 43205, USA.ORCID 0000-0001-8353-8794
Qing DuanDivision of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Nicholas J OllberdingDivision of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.ORCID 0000-0001-9404-7368
Elizabeth J ReverriNutrition Science & Innovation, Abbott Nutrition, Columbus, OH 43219, USA.ORCID 0000-0001-7692-0901
Rachael H BuckGut, Immunity, and Brain Health Platform, Abbott Nutrition, Columbus, OH 43219, USA.ORCID 0009-0008-0609-6900
Bridget Barrett-ReisNutrition Science & Innovation, Abbott Nutrition, Columbus, OH 43219, USA.
Kimberly YoltonDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.ORCID 0000-0002-4458-0516
Ardythe L MorrowDepartment of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.

Funding

Abbott Nutrition FS00012772
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dietary SupplementsInfant BehaviorInfant, PrematureTrisaccharidesDouble-Blind MethodFemaleGestational AgeHumansInfant, NewbornMaleMilk, HumanPilot Projects2'-fucosyllactoseTrisaccharides2′-Fucosyllactosegrowthhuman milk oligosaccharidesneurobehaviorpretermtolerance

Identifiers

PMID42588060
PMCPMC13467634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.